Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Per the FDA, compounded drugs that contain DSIP may pose a risk for immunogenicity,26 a state in which the body perceives a substance as a threat and so mounts a potentially life-threatening immune response against it
Decreased Inflammation
Injectable GHK-Cu for systemic use is available through peptide therapy providers and typically costs $100-200 per month
What we care about is is it doing something in the brain or the muscles or, you know, whatever
US$ 26.47
US$ 27.89
US$ 29.62
US$ 27.31
US$ 22.63
US$ 27.29
US$ 28.70
